The high-complexity lab selects Gestalt’s PathFlow platform to enhance laboratory workflows and extend capabilities to underserved regions.
OmniPathology, a high-complexity independent pathology laboratory, has selected Gestalt’s PathFlow digital pathology platform as part of a strategic partnership aimed at improving diagnostic workflows and expanding access to care in underserved communities.
The collaboration will integrate Gestalt’s AI-driven digital pathology platform with OmniPathology’s molecular and anatomic pathology services to streamline case management, reduce turnaround times, and enhance diagnostic accuracy.
“At Gestalt, we believe innovation must be paired with purpose,” says Lisa-Jean Clifford, president of Gestalt, in a release. “Our partnership with OmniPathology is not only about elevating laboratory performance—it’s about laying the groundwork for diagnostic access in underserved communities around the world.”
Focus on Global Health Impact
The partnership extends beyond technology implementation to include initiatives aimed at extending digital diagnostic capabilities to regions with limited healthcare infrastructure. The organizations plan to leverage AI and cloud-based technologies as learning and teaching tools to address gaps in care delivery.
OmniPathology brings specialized expertise in gastrointestinal pathology to the collaboration, which the company says will create synergies with Gestalt’s AI capabilities.
“At OmniPathology, our commitment to innovation goes beyond adopting new tools. It’s about shaping the future of diagnostics,” says Mohammad Kamal, MD, founder and chief executive officer of OmniPathology, in a release. “Partnering with Gestalt allows us to combine their world-class AI capabilities with our best-in-class leadership in GI pathology, creating powerful synergies that will enhance precision, efficiency, and improve outcomes for patients. Together, we see tremendous opportunities to advance pathology, accelerate discoveries in clinical research, and make a meaningful impact on global health.”
Platform Integration Details
The PathFlow platform is designed to provide scalable, interoperable solutions for laboratory diagnostics. The integration aims to improve precision and efficiency in diagnostic workflows while maintaining focus on patient outcomes.
The partnership emphasizes open, scalable platforms that can support broader industry adoption. Both organizations cite education access and continuous improvement as key priorities in their collaboration.
Gestalt specializes in digital pathology and AI-driven laboratory solutions, while OmniPathology operates as a high-complexity independent laboratory focusing on molecular and anatomic pathology services.
ID 32250921 © Raywoo | Dreamstime.com
